Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

REEP2 Activators

Activators of REEP2 function through a variety of biochemical mechanisms to influence its activity within the cell. Compounds that elevate intracellular cAMP levels, such as those that directly stimulate adenylyl cyclase or inhibit phosphodiesterase, lead to an increase in PKA activity. The subsequent phosphorylation cascade can result in the enhanced phosphorylation and activation of REEP2, as phosphorylation is a common regulatory mechanism for protein activation. Similarly, a cell-permeable cAMP analog can directly activate PKA, bypassing upstream signaling and exerting a similar effect on REEP2. Other activators include agents that modulate ion channel function, such as chloride channel blockers and sodium channel activators. By altering neuronal excitability, these compounds may indirectly initiate signaling events that culminate in the activation of REEP2, as changes in ion gradients and cellular excitability are known to influence a myriad of signaling pathways.

Additionally, compounds that interfere with cellular trafficking, such as those which disrupt ER to Golgi transport, could indirectly lead to the activation of REEP2 by affecting its localization and function within the cell. Certain natural compounds are known to modulate multiple signaling pathways, including those that influence PKA activity. Chemicals that modulate ion channel function might play a role in the indirect activation of REEP2 by perturbing cellular signaling on a broader scale. Lastly, alkaloids that promote sodium channel activation can increase neuronal activity and hence may influence pathways associated with REEP2 activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Phosphodiesterase inhibitor that prevents cAMP degradation, maintaining PKA activation, which can lead to the phosphorylation and activation of REEP2.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Selective phosphodiesterase 4 inhibitor, increasing cAMP levels and thus PKA activity, potentially leading to the phosphorylation and activation of REEP2.

Picrotoxin

124-87-8sc-202765
sc-202765A
sc-202765B
1 g
5 g
25 g
$67.00
$286.00
$1326.00
11
(3)

A chloride channel blocker that can alter neuronal excitability, indirectly affecting pathways that may involve the activation of REEP2.

Ouabain-d3 (Major)

sc-478417
1 mg
$516.00
(0)

Inhibits Na+/K+-ATPase, affecting ion gradients and cellular excitability, which can lead to the activation of signaling pathways involving REEP2.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts ER to Golgi transport, affecting cellular trafficking pathways that could indirectly lead to the activation of REEP2.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Modulates various signaling pathways, including the PKA pathway, which could lead to the activation of REEP2 through phosphorylation.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

Cell-permeable cAMP analog that activates PKA, potentially resulting in the phosphorylation and activation of REEP2.

Capsaicin

404-86-4sc-3577
sc-3577C
sc-3577D
sc-3577A
50 mg
250 mg
500 mg
1 g
$96.00
$160.00
$240.00
$405.00
26
(1)

Activates TRPV1 channels, influencing calcium signaling and potentially affecting pathways that lead to the activation of REEP2.

Veratridine

71-62-5sc-201075B
sc-201075
sc-201075C
sc-201075A
5 mg
10 mg
25 mg
50 mg
$82.00
$104.00
$201.00
$379.00
3
(1)

Alkaloid that activates sodium channels, leading to increased neuronal excitability and potentially the activation of REEP2-associated pathways.